Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers ...
BioMed X Institute is teaming up with the Barbados government in an effort to accelerate cardiometabolic treatments for ...
UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an ...
“Partnering with Genesis Therapeutics presents a unique opportunity to leverage their AI technologies to accelerate the ...
Clinical trial organization Flourish Research has made a deal with Diablo Clinical Research, acquiring the California-based facility and its expertise in endocrinology, cardiovascular and metabolic ...
CRISPR-based Spotlight Therapeutics has shut down, former CEO Mary Haak-Frendscho, Ph.D., confirmed with Fierce Biotech. | ...
Charles River expanded the Memphis facility in November 2022, adding nine processing suites to its 16 clean rooms at the site ...
After privately vying for a change to Dynavax’s corporate strategy for months, life sciences investment firm Deep Track ...
Salt Lake City-based accelerator Altitude Lab is hoping it can entice biotechs impacted by the uncertainty surrounding federal grants.
The imaging giant is leasing warehouse space and contracting inventory management through a multiyear deal with logistics ...
Cabaletta’s new data slice for its investigational CD19-CAR T cell therapy shows “robust benefit” for patients with lupus and ...
Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. | Ascletis Pharma’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results